Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Elite Pharmaceuticals Inc's Business Segments
Elite Pharmaceuticals Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
6
Largest Segment
Abbreviated New Drug Applications Revenue
Total Revenue
$ 32
Regions Reported
-
Revenue Share by Reportable Segment - FY
- Abbreviated New Drug Applications Revenue99.3%
- Scheduled Products Manufacturing Fees86%
- Direct Sales to Wholesalers50.7%
- Indirect Sales to Wholesalers48.6%
- Un Scheduled Products Manufacturing Fees13.4%
- Scheduled Products Licensing Fees0.7%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Abbreviated New Drug Applications Revenue | $ 32 | 99.3% |
| Scheduled Products Manufacturing Fees | $ 28 | 86% |
| Direct Sales to Wholesalers | $ 16 | 50.7% |
3 more segments available
Sign in to unlock the full Elite Pharmaceuticals Inc dataset.
Annual Results
Revenue Share by Reportable Segment - FY
- Abbreviated New Drug Applications Revenue99.3%
- Scheduled Products Manufacturing Fees86%
- Direct Sales to Wholesalers50.7%
- Indirect Sales to Wholesalers48.6%
- Un Scheduled Products Manufacturing Fees13.4%
- Scheduled Products Licensing Fees0.7%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Abbreviated New Drug Applications Revenue | $ 32 | 99.3% |
| Scheduled Products Manufacturing Fees | $ 28 | 86% |
| Direct Sales to Wholesalers | $ 16 | 50.7% |
3 more segments available
Sign in to unlock the full Elite Pharmaceuticals Inc dataset.
Revenue by Product & Service Category - FY
- Manufacturing99.3%
- Manufacturing Fees99.3%
- Scheduled Products Manufacturing Fees95%
- Indirect Sales to Wholesalers55.4%
- Direct Sales to Wholesalers43.8%
- Un Scheduled Products Manufacturing Fees4.3%
- Licensing0.7%
- Unscheduled Products Licensing Fees0.4%
- Scheduled Products Licensing Fees0.3%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Manufacturing | $ 148 | 99.3% |
| Manufacturing Fees | $ 148 | 99.3% |
| Scheduled Products Manufacturing Fees | $ 141 | 95% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
6 more categories available
Sign in to unlock the full Elite Pharmaceuticals Inc dataset.
Description of Elite Pharmaceuticals Inc
Elite Pharmaceuticals Inc. is a global pharmaceutical company that focuses on the development, manufacturing, and commercialization of generic and branded pharmaceutical products. The company has a strong presence in the US, Europe, and Asia, with the majority of its business coming from the United States. Elite Pharmaceuticals has been in operation since 1984 and is headquartered in Northvale, New Jersey.
One of the primary areas of focus for Elite Pharmaceuticals is controlled-release drug delivery systems. The company has developed a proprietary technology that allows for the controlled release of drugs over an extended period of time. This technology has been applied to a wide range of drugs, including opioids for pain management, ADHD medications, and other therapeutics.
Elite Pharmaceuticals manufactures its products through its wholly-owned subsidiary, Elite Laboratories Inc. The company has a state-of-the-art manufacturing facility in Northvale, New Jersey, which is approved by the US Food and Drug Administration (FDA) and has been audited by regulatory agencies in Europe and Asia.
In addition to its focus on controlled-release drug delivery systems, Elite Pharmaceuticals also has a pipeline of new products in development. The company collaborates with other pharmaceutical companies and research institutions to develop new therapeutics for a variety of indications.
Elite Pharmaceuticals has a strong track record of commercial success. The company has a portfolio of more than 20 products under various stages of development and has successfully launched several products in the US market. Elite Pharmaceuticals has also received numerous accolades and awards for its innovative drug delivery systems and manufacturing capabilities.
The company's leadership team is led by CEO and President, Nasrat Hakim, who has over 30 years of experience in the pharmaceutical industry. The company also has a team of experienced executives, scientists, and engineers who are dedicated to advancing Elite Pharmaceuticals' mission of improving human health through innovative drug delivery systems.
One of the primary areas of focus for Elite Pharmaceuticals is controlled-release drug delivery systems. The company has developed a proprietary technology that allows for the controlled release of drugs over an extended period of time. This technology has been applied to a wide range of drugs, including opioids for pain management, ADHD medications, and other therapeutics.
Elite Pharmaceuticals manufactures its products through its wholly-owned subsidiary, Elite Laboratories Inc. The company has a state-of-the-art manufacturing facility in Northvale, New Jersey, which is approved by the US Food and Drug Administration (FDA) and has been audited by regulatory agencies in Europe and Asia.
In addition to its focus on controlled-release drug delivery systems, Elite Pharmaceuticals also has a pipeline of new products in development. The company collaborates with other pharmaceutical companies and research institutions to develop new therapeutics for a variety of indications.
Elite Pharmaceuticals has a strong track record of commercial success. The company has a portfolio of more than 20 products under various stages of development and has successfully launched several products in the US market. Elite Pharmaceuticals has also received numerous accolades and awards for its innovative drug delivery systems and manufacturing capabilities.
The company's leadership team is led by CEO and President, Nasrat Hakim, who has over 30 years of experience in the pharmaceutical industry. The company also has a team of experienced executives, scientists, and engineers who are dedicated to advancing Elite Pharmaceuticals' mission of improving human health through innovative drug delivery systems.
Elite Pharmaceuticals Inc. operates as a specialty pharmaceutical company with a comprehensive and multifaceted approach to developing, manufacturing, and selling both generic and proprietary prescription drugs. The company’s business is structured into several distinct divisions, each contributing to its mission of enhancing healthcare through innovative drug solutions. Below is an extensive overview of the segments, products, and services offered by Elite Pharmaceuticals Inc.
1. Manufacturing and Sales Division
Overview
Elite Pharmaceuticals maintains a state-of-the-art manufacturing facility located in Northvale, New Jersey. This facility is equipped with advanced technologies that facilitate the production of solid oral dosage forms, including tablets and capsules. Additionally, the company boasts an FDA-approved manufacturing site in Spain dedicated to the production of generic pharmaceuticals.
Contract Manufacturing Services
Beyond in-house production, the Manufacturing and Sales Division offers contract manufacturing services to third-party pharmaceutical companies. This service is particularly valuable for those looking to leverage Elites expertise and capabilities without investing in their own manufacturing infrastructure.
Product Line
The manufacturing division oversees the production of several significant products ranging from generic drugs to proprietary formulations, focusing on quality and compliance with regulatory standards.
Research and Development Division
Overview
The Research and Development (R&D) Division at Elite Pharmaceuticals is central to the company’s growth and innovation strategy. This division is primarily involved in the discovery, development, and commercialization of new drug candidates.
Collaborations and Partnerships
Elite Pharmaceuticals engages in research collaborations with strategic partners and academic institutions, fostering innovation and tapping into external expertise. This cooperative approach allows for the accelerated development of drug candidates and enhances the company’s R&D output.
Innovative Formulations
The R&D Division has made significant strides in developing innovative formulations, particularly in pain management and opioid addiction therapies. These products are designed to meet the evolving medical needs of patients while addressing critical health issues such as the opioid epidemic.
Abuse-Deterrent Formulations Division
Overview
In response to the growing concerns related to opioid misuse, Elite Pharmaceuticals has established a division specifically focused on the development of abuse-deterrent formulations.
Elite ODT Technology
One of the hallmark innovations of this division is the proprietary Elite Orally Disintegrating Tablet (ODT) technology. This formulation is designed to deliver opioid medications in a way that significantly reduces the potential for abuse. The ODT technology aims to prevent common methods of misuse, such as converting tablets for injection or smoking, thereby providing a safer alternative for patients in need of pain management.
Generic Drug Division
Overview
The Generic Drug Division is a cornerstone of Elite Pharmaceuticals business model, providing a robust portfolio of FDA-approved generic products. This division is dedicated to increasing access to essential medications while maintaining high standards of quality and efficacy.
Therapeutic Areas
The company’s generic pharmaceutical offerings cover a broad spectrum of therapeutic areas, including but not limited to:
- Pain Management: Products such as Methadone hydrochloride tablets.
- Neurology: Dextroamphetamine sulfate tablets among others.
- Cardiovascular: Various medications addressing heart health.
- Urology: Products focused on urological conditions.
Competitive Position
With a strong emphasis on regulatory compliance and product quality, Elite has established itself as a key player in the generic drug market, competing effectively against other manufacturers while ensuring affordability and accessibility of its products.
Sales and Marketing Division
Overview
Elite Pharmaceuticals has developed a dedicated Sales and Marketing Division that plays a crucial role in promoting the company’s products across various healthcare settings, including hospitals, clinics, and pharmacies.
Strategies
The sales team employs strategic relationship-building tactics to enhance customer engagement and satisfaction, ensuring a steady demand for the company’s product lineup. Part of their strategy includes identifying new business opportunities that can drive revenue growth.
Market Penetration
The Marketing Division has a proven track record of successfully launching new products, expanding market share, and adapting to changing market dynamics through targeted marketing campaigns and outreach efforts.
Summary
Elite Pharmaceuticals Inc. stands out as a dynamic and diversified specialty pharmaceutical company. Through its various segments—Manufacturing and Sales, R&D, Abuse-Deterrent Formulations, Generic Drugs, and Sales and Marketing—it delivers a comprehensive range of products and services to the pharmaceutical industry. With strengths in advanced manufacturing capabilities, innovative research, and a robust pipeline of both generic and proprietary products, Elite Pharmaceuticals is well-equipped to contribute positively to the evolving landscape of healthcare.
1. Manufacturing and Sales Division
Overview
Elite Pharmaceuticals maintains a state-of-the-art manufacturing facility located in Northvale, New Jersey. This facility is equipped with advanced technologies that facilitate the production of solid oral dosage forms, including tablets and capsules. Additionally, the company boasts an FDA-approved manufacturing site in Spain dedicated to the production of generic pharmaceuticals.
Contract Manufacturing Services
Beyond in-house production, the Manufacturing and Sales Division offers contract manufacturing services to third-party pharmaceutical companies. This service is particularly valuable for those looking to leverage Elites expertise and capabilities without investing in their own manufacturing infrastructure.
Product Line
The manufacturing division oversees the production of several significant products ranging from generic drugs to proprietary formulations, focusing on quality and compliance with regulatory standards.
Research and Development Division
Overview
The Research and Development (R&D) Division at Elite Pharmaceuticals is central to the company’s growth and innovation strategy. This division is primarily involved in the discovery, development, and commercialization of new drug candidates.
Collaborations and Partnerships
Elite Pharmaceuticals engages in research collaborations with strategic partners and academic institutions, fostering innovation and tapping into external expertise. This cooperative approach allows for the accelerated development of drug candidates and enhances the company’s R&D output.
Innovative Formulations
The R&D Division has made significant strides in developing innovative formulations, particularly in pain management and opioid addiction therapies. These products are designed to meet the evolving medical needs of patients while addressing critical health issues such as the opioid epidemic.
Abuse-Deterrent Formulations Division
Overview
In response to the growing concerns related to opioid misuse, Elite Pharmaceuticals has established a division specifically focused on the development of abuse-deterrent formulations.
Elite ODT Technology
One of the hallmark innovations of this division is the proprietary Elite Orally Disintegrating Tablet (ODT) technology. This formulation is designed to deliver opioid medications in a way that significantly reduces the potential for abuse. The ODT technology aims to prevent common methods of misuse, such as converting tablets for injection or smoking, thereby providing a safer alternative for patients in need of pain management.
Generic Drug Division
Overview
The Generic Drug Division is a cornerstone of Elite Pharmaceuticals business model, providing a robust portfolio of FDA-approved generic products. This division is dedicated to increasing access to essential medications while maintaining high standards of quality and efficacy.
Therapeutic Areas
The company’s generic pharmaceutical offerings cover a broad spectrum of therapeutic areas, including but not limited to:
- Pain Management: Products such as Methadone hydrochloride tablets.
- Neurology: Dextroamphetamine sulfate tablets among others.
- Cardiovascular: Various medications addressing heart health.
- Urology: Products focused on urological conditions.
Competitive Position
With a strong emphasis on regulatory compliance and product quality, Elite has established itself as a key player in the generic drug market, competing effectively against other manufacturers while ensuring affordability and accessibility of its products.
Sales and Marketing Division
Overview
Elite Pharmaceuticals has developed a dedicated Sales and Marketing Division that plays a crucial role in promoting the company’s products across various healthcare settings, including hospitals, clinics, and pharmacies.
Strategies
The sales team employs strategic relationship-building tactics to enhance customer engagement and satisfaction, ensuring a steady demand for the company’s product lineup. Part of their strategy includes identifying new business opportunities that can drive revenue growth.
Market Penetration
The Marketing Division has a proven track record of successfully launching new products, expanding market share, and adapting to changing market dynamics through targeted marketing campaigns and outreach efforts.
Summary
Elite Pharmaceuticals Inc. stands out as a dynamic and diversified specialty pharmaceutical company. Through its various segments—Manufacturing and Sales, R&D, Abuse-Deterrent Formulations, Generic Drugs, and Sales and Marketing—it delivers a comprehensive range of products and services to the pharmaceutical industry. With strengths in advanced manufacturing capabilities, innovative research, and a robust pipeline of both generic and proprietary products, Elite Pharmaceuticals is well-equipped to contribute positively to the evolving landscape of healthcare.